NEUROBORRELIOSIS

This adverse event was reported 76 times

NEUROBORRELIOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LEUPROLIDE ACETATE AND NORETHINDRONE ACETATE 1 0.0023
1 TROSPIUM CHLORIDE 1 0.0010
2 CLINDAMYCIN HYDROCHLORIDE 1 0.0009
3 ESTAZOLAM 1 0.0009
4 CROMOLYN SODIUM 1 0.0005
5 SUFENTANIL 1 0.0004
6 BENDAMUSTINE HYDROCHLORIDE 2 0.0003
7 HYDROXYZINE HCL 1 0.0002
8 NOREPINEPHRINE (BITARTRATE) 1 0.0002
9 CEFTRIAXONE SODIUM 4 0.0002
See all drugs enriched for association with NEUROBORRELIOSIS

These drug classes are most commonly taken by patients reporting NEUROBORRELIOSIS:

# Drug class Count
0 Angiotensin Converting Enzyme Inhibitor [EPC] 2
1 Purine Antimetabolite [EPC] 1
2 Tetracycline-class Drug [EPC] 1
See all common drug classes associated with NEUROBORRELIOSIS

NEUROBORRELIOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tetracycline-class Drug [EPC] 1 0.0000
1 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
2 Purine Antimetabolite [EPC] 1 0.0000
See all drug classes enriched for association with NEUROBORRELIOSIS